Pharmicell Co., Ltd. (KRX:005690)

Pharmicell Revenue

Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's revenue in the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth.

• Revenue (ttm): 23.94B
• Revenue Growth: -3.60%
• P/S Ratio: 33.32
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 797.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2013	33.41B	22.29B	200.63%
Dec 31, 2012	11.11B	829.38M	8.07%
Dec 31, 2011	10.28B	3.07B	42.47%
Dec 31, 2010	7.22B	28.94M	0.40%
Dec 31, 2009	7.19B	-1.14B	-13.68%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2014

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error